Three New York state companies have been chosen to participate in the Cornell Center for Materials Research JumpStart Program, through which they will collaborate with faculty members to develop and improve their products.
According to new research out of Weill Cornell Medicine, a protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body.
Cornell's Office of Academic Integration has announced 15 new multi-investigator seed grants, including support for a project on climate change, pollen and asthma attacks and another to develop a microbial delivery system for a unique treatment of colorectal cancer.
New evidence from a zebrafish model of epilepsy may help resolve a debate into how seizures originate, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings may also be useful in the discovery and development of future epilepsy drugs.
The center, with more than 120 faculty members, builds on the multidisciplinary nature of research into the immune system, with links between infection biology, vaccine development, genetics, genomics, malignancy and biomedical engineering.
Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer’s and some other neurodegenerative diseases, a study by Weill Cornell Medicine investigators suggests.
The Baker Institute for Animal Health has evolved and grown since its founding 70 years ago, and its breakthroughs regarding canine infectious diseases have established it as a global center for animal health research.
Breeding Insight, a new program funded by the U.S. Department of Agriculture through Cornell University, will share latest tools with breeders in the U.S.
The funding will support preliminary disease-related research, in the latest in a series of efforts to create new opportunities for interdisciplinary research.